Solta Medical, Inc. (the "Company") held its 2012 Annual Meeting of Stockholders ("Annual Meeting") on June 7, 2012, to vote on the following proposals:

1. Election of three Class III directors, Cathy L. McCarthy, Mark M. Sieczkarek and Eric Stang, to serve a three year term which will expire at the 2015 Annual Meeting of Stockholders or until such time as their respective successors have been duly elected and qualified. All directors were elected in accordance with the votes below:

      Nominees              Shares For       Shares Withheld       Broker Non-Votes
      Cathy L. McCarthy      35,853,224             3,329,280             14,099,971
      Mark M. Sieczkarek     35,825,454             3,357,050             14,099,971
      Eric Stang             35,008,918             4,173,586             14,099,971

2. Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2012. Deloitte & Touche LLP was ratified as our independent registered public accounting firm for the fiscal year ending December 31, 2012 in accordance with the votes below:

Shares For Shares Against Shares Abstaining Broker Non-Votes 53,070,577 114,520 97,378 0

3. Advisory Vote on executive compensation. The shareholders voted to approve the compensation of our named officers in accordance with the votes below:

Shares For Shares Against Shares Abstaining Broker Non-Votes 37,140,036 529,492 1,512,976 14,099,971

4. Amendment of our Amended and Restated Certificate of Incorporation to eliminate the supermajority voting threshold. The Amendment of our Amended and Restated Certificate of Incorporation required a vote of 66-2/3% of the outstanding stock. It was not approved in accordance with the votes below:

Shares For Shares Against Shares Abstaining Broker Non-Votes 37,583,260 199,872 1,399,372 14,099,971